CMS adds enforcement flexibility for exchanges' COVID-19-related payment decisions
The Centers for Medicare & Medicaid Services yesterday issued an FAQ to outline COVID-19-related payment and grace period flexibilities for issuers offering coverage on the federally-facilitated exchanges and state-based exchanges on the federal platform. The agency says it will “exercise enforcement discretion” if issuers extend premium payment deadlines and delay cancellations or terminations of coverage for non-payment of premiums, assuming these are done with the permission of applicable state regulatory authorities. CMS also is encouraging state-based exchanges to take a similar approach. CMS also released the following FAQs:
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…